TickerFactsScreenerDevelopers

Protara Therapeutics, Inc. (TARA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $3.27M2012: $2.41M2013: $2.79M2014: $68.84M2015: $40.03M2016: $36.39M2017: $21.17M2018: $19.37M2019: $564.0K2020: $168.60M2021: $35.72M2022: $24.13M2023: $39.59M2024: $162.80M2025: $49.66M$49.66M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$49.66M-69.5%
2024$162.80M+311.3%
2023$39.59M+64.1%
2022$24.13M-32.5%
2021$35.72M-78.8%
2020$168.60M+29793.3%
2019$564.0K-97.1%
2018$19.37M-8.5%
2017$21.17M-41.8%
2016$36.39M-9.1%
2015$40.03M-41.8%
2014$68.84M+2364.7%
2013$2.79M+15.9%
2012$2.41M-26.3%
2011$3.27M—